Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 561 INDUSTRY 175 NIH 81 NETWORK 47 UNKNOWN 5 OTHER_GOV 3 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 1

Interventions

Exercise 6 pembrolizumab 5 enzalutamide 4 Docetaxel 4 Colonoscopy 4 Celecoxib 4 sargramostim 3 apalutamide 3 Prednisone 3 Methods 3 Leuprolide 3 Itraconazole 3 Imiquimod 3 Granulocyte-Macrophage Colony-Stimulating Factor 3 Golytely 3 Cryotherapy 3 Abiraterone Acetate 3 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 3 abiraterone 2 Yoga 2 Topotecan 2 Testosterone 2 Tablets 2 Simvastatin 2 Radiosurgery 2 Palliative Care 2 Midazolam 2 Gelatin 2 Decision Support Techniques 2 Collagenases 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

FED × Temozolomide × Clear all

NCT06681220 2026-03-11

Relapsed SCLC

VA Office of Research and Development

Phase 1/2 Recruiting

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡